Evidence map›Paper›PMID 42824340›Full record

ArticleMolecular genetics and metabolism reports2026

Classic Ataxia-Telangiectasia associated with a homozygous missense ATM variant: A case report.

Zyad Al-Frejat, Leen Azzam, Grace Hanna, Doaa Abo Hamza, Ghuroub Al Khayer

Abstract readCase Reports
In one paragraph

Article in Molecular genetics and metabolism reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zyad Al-FrejatDepartment of Radiology, Damascus University, Syria.
Leen AzzamFaculty of Dentistrty, Damascus University, Syria.
Grace HannaDepartment of Radiology, Damascus University, Syria.
Doaa Abo HamzaDepartment of Pediatrics, Damascus University, Syria.
Ghuroub Al KhayerDepartment of Pediatrics, Damascus University, Syria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by mutations in the ATM gene, characterized by progressive cerebellar ataxia, telangiectasias, immunodeficiency, and increased cancer risk Reporting the phenotypic spectrum of ATM variants is essential to refine genotype-phenotype correlations. We report a 6-year-old boy presenting with progressive gait ataxia, recurrent respiratory infections, chronic otorrhea, and conjunctival telangiectasias. Laboratory studies revealed immunodeficiency with reduced IgG and IgA, and elevated IgM. Brain MRI showed mild cerebellar atrophy, while chest X-ray revealed bilateral interstitial infiltrates. Whole-exome sequencing identified a homozygous missense variant in ATM (c.4940 T > G; p.Leu1647Arg), currently classified as a variant of uncertain significance (VUS); this represents only the second reported family with this variant.The patient improved with intravenous antibiotics and IVIG. Family genetic testing was recommended given parental consanguinity and an affected sibling. This case illustrates the classical phenotype of A-T with immunodeficiency and neurological dysfunction. Such cases reinforce genotype-phenotype correlations and may guide diagnosis and counseling. Although the variant's pathogenicity remains to be functionally validated, its clinical correlation supports disease relevance. Careful clinical and familial correlation of ATM variants is crucial for advancing diagnostic precision, genetic counseling, and future therapeutic strategies in A-T.

Indexed as

Ataxia TelangiectasiaCase reportsGeneticsMutation

Identifiers

PMID42824340
PMCPMC13627820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.